Group B Transcriptome when Interacting with Brain Endothelial Cells
Overview
Authors
Affiliations
Importance: Group B (GBS) meningitis remains the leading cause of neonatal meningitis. Research work has identified surface factors and two-component systems that contribute to GBS disruption of the blood-brain barrier (BBB). These discoveries often relied on genetic screening approaches. Here, we provide transcriptomic data describing how GBS changes its transcriptome when interacting with brain endothelial cells. Additionally, we have phenotypically validated these data by obtaining mutants of a select regulator that is highly down-regulated during infection and testing on our BBB model. This work provides the research field with a validated data set that can provide an insight into potential pathways that GBS requires to interact with the BBB and open the door to new discoveries.
Kordbacheh R, Ashley M, Cutts W, Keyzer T, Chatterjee S, Altman T Viruses. 2025; 16(12.
PMID: 39772131 PMC: 11680387. DOI: 10.3390/v16121821.
Hathcock S, Mamana J, Keyzer T, Vollmuth N, Shokri M, Mauser H J Virol. 2024; 99(1):e0182424.
PMID: 39670741 PMC: 11784093. DOI: 10.1128/jvi.01824-24.
strain COH1 transcriptome in association with stem cell-derived brain-like endothelial cells.
Vollmuth N, Sauerwein T, Foerstner K, Westermann A, Schubert-Unkmeir A, Lam D Microbiol Resour Announc. 2024; 13(12):e0045524.
PMID: 39526785 PMC: 11636360. DOI: 10.1128/mra.00455-24.